CN106432122B - A kind of preparation method of meropenem intermediate chlorine propionyl spiral shell benzoxazine hexamethylene - Google Patents

A kind of preparation method of meropenem intermediate chlorine propionyl spiral shell benzoxazine hexamethylene Download PDF

Info

Publication number
CN106432122B
CN106432122B CN201610812510.8A CN201610812510A CN106432122B CN 106432122 B CN106432122 B CN 106432122B CN 201610812510 A CN201610812510 A CN 201610812510A CN 106432122 B CN106432122 B CN 106432122B
Authority
CN
China
Prior art keywords
hexamethylene
benzoxazine
spiral shell
dihydro
ketone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610812510.8A
Other languages
Chinese (zh)
Other versions
CN106432122A (en
Inventor
路生辉
李国祥
布文安
袁小二
申友明
任伟
段振晓
李瑞华
卢现
李延龙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHENZHEN HAIBIN PHARMACEUTICAL CO Ltd
XINXIANG HAIBIN PHARMACEUTICAL CO Ltd
Original Assignee
SHENZHEN HAIBIN PHARMACEUTICAL CO Ltd
XINXIANG HAIBIN PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHENZHEN HAIBIN PHARMACEUTICAL CO Ltd, XINXIANG HAIBIN PHARMACEUTICAL CO Ltd filed Critical SHENZHEN HAIBIN PHARMACEUTICAL CO Ltd
Priority to CN201610812510.8A priority Critical patent/CN106432122B/en
Publication of CN106432122A publication Critical patent/CN106432122A/en
Application granted granted Critical
Publication of CN106432122B publication Critical patent/CN106432122B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/201,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22Oxygen atoms

Abstract

The present invention provides a kind of preparation methods of meropenem intermediate chlorine propionyl spiral shell benzoxazine hexamethylene, use the lower α-chlorpromazine chloride of reactivity, cooperate specific raw material one to work, not but not reduces reaction yield, instead reaction yield is greatly improved;Simultaneously, since α-chlorpromazine chloride activity is lower, so that the side reaction for participating in reaction is less, the impurity in products obtained from is less, to which yield and the higher chlorine propionyl spiral shell benzoxazine hexamethylene of purity be made, and this yield and the higher chlorine propionyl spiral shell benzoxazine hexamethylene of purity can replace Spirobromin benzoxazine hexamethylene to prepare Meropenem.In addition, without magnetic solid base catalyst, reaction condition is safer in the synthesis technology of chlorine propionyl spiral shell benzoxazine hexamethylene provided by the invention, reaction route is simple, convenient post-treatment, and raw material and catalyst are cheap and easy to get, safety and environmental protection, preparation cost is lower, is more suitable for industrialized production.

Description

A kind of preparation method of meropenem intermediate chlorine propionyl spiral shell benzoxazine hexamethylene
Technical field
The present invention relates to technical field of medicine synthesis more particularly to a kind of meropenem intermediate chlorine propionyl spiral shell benzoxazines The preparation method of hexamethylene.
Background technique
Meropenem also known as SM 7338, English name: Meropenem, chemical name: (4R, 5S, 6S) -3- [[(3S, 5S) - 5- (dimethylcarbamoyl) -3- pyrrolidines] sulphur] -6- [(1R) -1- ethoxy] -4- methyl -7- oxygen -1- nitrogen is bicyclic [3.2.0] Hept-2-ene" -2- carboxylic acid trihydrate is developed by Dainippon Sumitomo Pharma and Astrazeneca AB earliest, And listed first in Italy in nineteen ninety-five, then gradually had a vast market foreground in whole world application listing.As second There is has a broad antifungal spectrum compared to other similar antibiotic for carbapenem antibiotic, antibacterial action is strong, stablizes to DHP-1 enzyme The advantages that, it is mainly used for treating the serious bacterial infections such as respiratory tract infection, abdominal cavity infection, urinary tract infections, excellent.
The quality of key intermediate one of of the Spirobromin benzoxazine hexamethylene as synthesis Meropenem, quality is straight Connect the yield and quality for influencing Meropenem.Shown in the structure such as formula (II) of Spirobromin benzoxazine hexamethylene.However, adopting The yield of the Meropenem made from Spirobromin benzoxazine hexamethylene is not high.Meanwhile preparing Spirobromin benzoxazine The α of raw material required for hexamethylene-bromopropionyl bromide is expensive, smell is larger, and toxicity is higher.
The Chinese patent that number of patent application is 201110203766.6 disclose a kind of 3- (2- bromine propiono)-spiral shell [2H-1, 3- benzoxazine -2,1'- hexamethylene] -4 (3H) -one preparation method, this method is that starting is former with salicylamide and cyclohexanone Material, under the action of solid acid catalyst, reacts to obtain spiral shell [2H-1,3- benzoxazine -2,1'- hexamethylene in reflux in toluene Alkane] -4 (3H) -one;Then it under the action of magnetic solid base catalyst, reacts to obtain 3- (2- bromine with halogen acyl halide in toluene Propiono) -4 (3H) -one of-spiral shell [2H-1,3- benzoxazine -2,1'- hexamethylene], wherein halogen acyl halide is α-bromopropionyl bromide.
Spirobromin benzoxazine hexamethylene yield and purity made from this method are lower, meanwhile, it needs to adopt in preparation The complicated and expensive magnetic solid base catalyst with production process, reaction process is complicated, and the dangerous system of reaction is higher, after Processing is complicated, and environmental pollution is serious, higher cost.
Summary of the invention
In view of this, the technical problem to be solved in the present invention is that providing a kind of meropenem intermediate chlorine propionyl spiral shell benzo The preparation method of oxazines hexamethylene, the chlorine propionyl spiral shell benzoxazine hexamethylene prepared by this method can substitute Spirobromin benzene And oxazines hexamethylene prepares Meropenem, and the yield of chlorine propionyl spiral shell benzoxazine hexamethylene and purity are higher.
The present invention provides a kind of preparation methods of meropenem intermediate chlorine propionyl spiral shell benzoxazine hexamethylene, including with Lower step: by spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone and α-chlorpromazine chloride acid binding agent work Condensation reaction is carried out in aprotic solvent under, obtains chlorine propionyl spiral shell benzoxazine hexamethylene.
Preferably, it spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride and ties up The molar ratio of sour agent is 1:1.0~2.5:0.5~3.0.
Preferably, spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone and aprotic solvent Mass ratio is 1:1.0~5.0.
Preferably, the acid binding agent includes one or more of organic base and inorganic base.
Preferably, the organic base includes triethylamine, pyridine, n,N-diisopropylethylamine, 4-dimethylaminopyridine, three second One or more of hydramine and quaternary ammonium salt.
Preferably, the inorganic base includes one or more of potassium carbonate, ammonium carbonate and sodium carbonate.
Preferably, the aprotic solvent be toluene, dimethylbenzene, benzene, chlorobenzene, nitrobenzene, acetone, dimethylformamide, One or more of tetrahydrofuran, methylene chloride, chloroform and carbon tetrachloride.
Preferably, the temperature of the condensation reaction is room temperature to reflux temperature, the time of the condensation reaction is 0.5~ 20h。
Preferably, the condensation reaction carries out under the conditions of protecting existing for gas.
It preferably, further include the crystallization that cools down in proton solvent after the condensation reaction.
The present invention provides a kind of preparation methods of meropenem intermediate chlorine propionyl spiral shell benzoxazine hexamethylene, including with Lower step: by spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone and α-chlorpromazine chloride acid binding agent work Condensation reaction is carried out in aprotic solvent under, obtains chlorine propionyl spiral shell benzoxazine hexamethylene.With disclosed in the prior art It prepares Spirobromin benzoxazine hexamethylene using α-bromopropionyl bromide to compare, the present invention uses the lower α of reactivity-chlorine propionyl Chlorine cooperates specific raw material one to work, and not but not reduces reaction yield, instead reaction yield is greatly improved; Simultaneously as α-chlorpromazine chloride activity it is lower so that participate in reaction side reaction it is less, the impurity in products obtained from compared with It is few, so that yield and the higher chlorine propionyl spiral shell benzoxazine hexamethylene of purity has been made, and this yield and the higher chlorine of purity Propionyl spiral shell benzoxazine hexamethylene can replace Spirobromin benzoxazine hexamethylene to prepare Meropenem.In addition, the present invention mentions In the synthesis technology of the chlorine propionyl spiral shell benzoxazine hexamethylene of confession, without magnetic solid base catalyst, reaction condition is more Safety, reaction route is simple, convenient post-treatment, and raw material and catalyst are cheap and easy to get, and safety and environmental protection, preparation cost is lower, more suitable Close industrialized production.
Specific embodiment
Below in conjunction with the embodiment of the present invention, technical solution of the present invention is clearly and completely described, it is clear that institute The embodiment of description is only a part of the embodiment of the present invention, instead of all the embodiments.Based on the embodiments of the present invention, Every other embodiment obtained by those of ordinary skill in the art without making creative efforts, belongs to this hair The range of bright protection.
The present invention provides a kind of preparation methods of meropenem intermediate chlorine propionyl spiral shell benzoxazine hexamethylene, including with Lower step:
By spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone and α-chlorpromazine chloride acid binding agent work Condensation reaction is carried out in aprotic solvent under, obtains chlorine propionyl spiral shell benzoxazine hexamethylene.
Preferably, specifically: under the conditions of protecting existing for gas, by spiral shell [2,3- dihydro -4H-1,3- Benzoxazines -2,1'- Hexamethylene] -4- ketone, α-chlorpromazine chloride, acid binding agent and aprotic solvent mixing, condensation reaction is carried out, chlorine propionyl spiral shell benzo is obtained Oxazines hexamethylene.
The present invention has no special limitation to the protective gas, is using protective gas well known to those skilled in the art Can, present invention preferably employs nitrogen.
Spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- the hexamethylene] -4- ketone has to be tied as shown in formula (III) Structure:
α-the chlorpromazine chloride has the structure as shown in formula (IV):
The acid binding agent includes one or more of organic base and inorganic base.The organic base preferably include triethylamine, Pyridine, N, one or more of N- diisopropylethylamine, 4-dimethylaminopyridine, triethanolamine and quaternary ammonium salt.The quaternary ammonium Salt is preferably tetrabutylammonium bromide, tetrabutylammonium chloride, benzyltriethylammonium chloride, cetyl trimethylammonium bromide, chlorination In the double octadecyldimethyl ammoniums of dodecyl dimethyl hexadecyldimethyl benzyl ammonium, bromination, octadecyldimethyl hydroxyethyl ammonium nitrate It is one or more of.The inorganic base preferably includes one or more of potassium carbonate, ammonium carbonate and sodium carbonate.
The aprotic solvent is preferably toluene, dimethylbenzene, benzene, chlorobenzene, nitrobenzene, acetone, dimethylformamide, tetrahydro One or more of furans, methylene chloride, chloroform and carbon tetrachloride.
In the present invention, spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride Molar ratio with acid binding agent is preferably 1:1.0~2.5:0.5~3.0;More preferably 1:1.4~1.6:0.8~1.4.In this hair In bright some embodiments, spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride with The molar ratio of acid binding agent is 1:1.4:1.2;Or 1:1.5:0.8;Or 1:1.6:1.4;Or 1:1.5:1.3;Or 1:1.6:1.3;Or 1:1.6:1.1;Or 1:1.6:1.2 or 1:1.0:0.5.
In the present invention, spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone with it is non-proton molten The mass ratio of agent is preferably 1:1.0~5.0;More preferably 1:3.0~5.0.In certain embodiments of the present invention, the spiral shell The mass ratio of [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone and aprotic solvent is 1:3.1;Or 1:3.7; Or 1:4.4;Or 1:5.
The present invention has no special limitation to the device of the condensation reaction, and the present invention is preferably four-hole boiling flask.
The temperature of the condensation reaction is preferably room temperature to reflux temperature, more preferably 50~90 DEG C;In certain of the invention In a little embodiments, the temperature of the condensation reaction is 50 DEG C, 55 DEG C, 60 DEG C, 70 DEG C, 80 DEG C, 90 DEG C.
The time of the condensation reaction is preferably 0.5~20h, more preferably 4.5~8h;In certain embodiments of the present invention In, the time of the condensation reaction is 3.5h, 5h, 6h, 7h or 8h.
After the condensation reaction, the crystallization that cools down is preferably also included in proton solvent.Preferably, the cooling crystallization is specific Are as follows: after being cooled to crystallization temperature, the crystallization in stirring.
The proton solvent is preferably one or more of alcohols solvent, more preferably methanol, ethyl alcohol, isopropanol, just One or more of butanol and the tert-butyl alcohol.In the present invention, the proton solvent and spiral shell [2,3- dihydro -4H-1,3- benzos Piperazine -2,1'- hexamethylene] mass ratio of -4- ketone is preferably 0.5~5.0:1, more preferably 1~2:1.In certain realities of the invention It applies in example, the mass ratio of the proton solvent and spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone is 1: 1,1.5:1 or 4:1.
The present invention has no special limitation to the mode of above-mentioned cooling, using cooling method well known to those skilled in the art ?.The present invention has no special limitation to the mode of the stirring, is using agitating mode well known to those skilled in the art It can.The temperature of the crystallization is preferably -20~10 DEG C;In certain embodiments of the present invention, the temperature of the crystallization is -5 DEG C. The time of the crystallization is preferably 1~3h;In certain embodiments of the present invention, the time of the crystallization is 2h.
Before the crystallization that cools down in proton solvent, it is also preferable to include be cooled to room temperature, clean, be concentrated under reduced pressure;It is described Cool down after crystallization in proton solvent, it is also preferable to include filterings and drying.
In the present invention, it is preferred to, the cleaning specifically: first washed three times with the first clear water, then washed three times with lye, most It is washed three times with the second clear water afterwards.The present invention has no special limitation to first clear water and the second clear water, using this field skill Clear water known to art personnel, the present invention are preferred are as follows: the first clear water and the second clear water are deionized water.The present invention is to described Lye and its mass percent have no special limitation, using alkaline solution well known to those skilled in the art and its quality percentage Number, the present invention are preferably sodium hydroxide solution, potassium hydroxide solution, sodium bicarbonate solution, potassium bicarbonate solution, sodium carbonate One or more of solution, solution of potassium carbonate.The mass percent of the alkaline solution is preferably 0.5%~20%.It is described The mass ratio of first clear water, lye and the second clear water is preferably 1.5~4:2~4:1.5~4.The lye and the spiral shell [2,3- Dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] mass ratio of -4- ketone is preferably 2~4:1~1.5.
The present invention has no special limitation to the device and method of the reduced pressure, using known to those skilled in the art Device and method are concentrated under reduced pressure, the present invention has no special limitation to the pressure of reduced pressure and time simultaneously, depressurizes dense It is reduced to no liquid outflow.The present invention has no special limitation to the device and method of the filtering and drying, using ability The device and method of filtering and drying known to field technique personnel.
The present invention has no special limitation to the source of above-mentioned used raw material, the product bought in the market.
Final product meropenem intermediate chlorine propionyl spiral shell benzoxazine hexamethylene obtained has to be tied as shown in formula (I) Structure:
The present invention provides a kind of preparation methods of meropenem intermediate chlorine propionyl spiral shell benzoxazine hexamethylene, including with Lower step: by spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone and α-chlorpromazine chloride acid binding agent work Condensation reaction is carried out in aprotic solvent under, obtains chlorine propionyl spiral shell benzoxazine hexamethylene.The present invention uses reactivity Lower α-chlorpromazine chloride, cooperation acid binding agent work with other raw materials one, not but not reduce reaction yield, make instead anti- Yield is answered to be greatly improved;Simultaneously as α-chlorpromazine chloride activity is lower, so that the side reaction for participating in reaction is less, into Obtained from impurity in products it is less.The present invention obtains yield and purity by further controlling reaction temperature and material proportion Higher chlorine propionyl spiral shell benzoxazine hexamethylene, and this yield and the higher chlorine propionyl spiral shell benzoxazine hexamethylene of purity can be with Spirobromin benzoxazine hexamethylene is replaced to prepare Meropenem.In addition, chlorine propionyl spiral shell benzoxazine hexamethylene provided by the invention In the synthesis technology of alkane, reaction condition is safer, and reaction route is simple, convenient post-treatment, and raw material and catalyst are cheap and easy to get, Safety and environmental protection, preparation cost is lower, is more suitable for industrialized production.
In order to further illustrate the present invention, with reference to embodiments to a kind of meropenem intermediate chlorine provided by the invention The preparation method of propionyl spiral shell benzoxazine hexamethylene is described in detail, but cannot be understood as to the scope of the present invention It limits.
Embodiment 1
According to spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride and triethylamine Molar ratio is 1:1.4:1.2, weigh respectively 80g spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride of 65g and the triethylamine of 45g;According to spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone Mass ratio with toluene is 1:3.1, weighs 250g toluene;According to [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] - The mass ratio of 4- ketone and isopropanol is 1:1, weighs 80g isopropanol.
Under nitrogen protection, by toluene, spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorine Propionyl chloride and triethylamine, which are added in four-hole boiling flask, to be reacted, and the temperature of the reaction is 80 DEG C, and the time of reaction is 5h.Reaction After, it is down to room temperature, respectively three times with 200g washing, is washed three times with the sodium hydroxide solution of 200g8%, with 200g washing three It is secondary, merge organic phase, is concentrated under reduced pressure into no liquid outflow.Then isopropanol is added, is cooled to -5 DEG C, stirring and crystallizing 2h, filters, Drying, obtains chlorine propionyl spiral shell benzoxazine hexamethylene 106.5g.Its molar yield is 94.1%, purity 99.6%.
Embodiment 2
According to spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride and 4- diformazan ammonia The molar ratio of yl pyridines is 1:1.5:0.8, weighs spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylenes of 80g respectively Alkane] -4- ketone, α-chlorpromazine chloride of 70g and the 4-dimethylaminopyridine of 38g;According to spiral shell [2,3- dihydro -4H-1,3- Benzoxazine - 2,1'- hexamethylenes] mass ratio of -4- ketone and dimethylbenzene is 1:3.7, weigh 300g dimethylbenzene;According to [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] mass ratio of -4- ketone and n-butanol is 1:1, weigh 80g n-butanol.
Under nitrogen protection, by dimethylbenzene, spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α - Chlorpromazine chloride and 4-dimethylaminopyridine, which are added in four-hole boiling flask, is reacted, and the temperature of the reaction is 90 DEG C, reaction when Between be 4.5h.After reaction, it is down to room temperature, respectively three times with 200g washing, washes three with the sodium bicarbonate solution of 250g10% It is secondary, three times with 200g washing, merge organic phase, is concentrated under reduced pressure into no liquid outflow.Then n-butanol is added, is cooled to -5 DEG C, Stirring and crystallizing 2h is filtered, and drying obtains chlorine propionyl spiral shell benzoxazine hexamethylene 104.8g.Its molar yield is 92.5%, purity It is 99.3%.
Embodiment 3
According to rubbing for spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride and pyridine You weigh spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, 75g of 80g than being 1:1.6:1.4 respectively α-chlorpromazine chloride and 40g pyridine;According to spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone and chlorobenzene Mass ratio be 1:4.4, weigh 350g chlorobenzene;According to [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone with The mass ratio of ethyl alcohol is 1:1, weighs 80g ethyl alcohol.
Under nitrogen protection, by chlorobenzene, spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorine Propionyl chloride and pyridine, which are added in four-hole boiling flask, to be reacted, and the temperature of the reaction is 50 DEG C, and the time of reaction is 8h.Reaction knot Shu Hou is down to room temperature, respectively three times with 200g washing, is washed three times with the potassium hydroxide solution of 200g10%, with 200g washing three It is secondary, merge organic phase, is concentrated under reduced pressure into no liquid outflow.Then ethyl alcohol is added, is cooled to -5 DEG C, stirring and crystallizing 2h, filters, dries It is dry, obtain chlorine propionyl spiral shell benzoxazine hexamethylene 107.6g.Its molar yield is 95.0%, purity 99.7%.
Embodiment 4
According to spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride and triethanolamine Molar ratio be 1:1.5:1.3, weigh respectively 80g spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride of 70g and the triethanolamine of 70g;According to spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- The mass ratio of ketone and benzene is 1:5, weighs 400g benzene;According to [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone Mass ratio with methanol is 1:1, weighs 80g methanol.
Under nitrogen protection, by benzene, spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorine third Acyl chlorides and triethanolamine, which are added in four-hole boiling flask, to be reacted, and the temperature of the reaction is 80 DEG C, and the time of reaction is 6h.Reaction After, it is down to room temperature, respectively three times with 200g washing, is washed three times with the potassium bicarbonate solution of 250g10%, is washed with 200g Three times, merge organic phase, be concentrated under reduced pressure into no liquid outflow.Then methanol is added, is cooled to -5 DEG C, stirring and crystallizing 2h, filters, Drying, obtains chlorine propionyl spiral shell benzoxazine hexamethylene 104.1g.Its molar yield is 91.9%, purity 99.4%.
Embodiment 5
It is different according to spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride and N, N- bis- The molar ratio of propylethylamine is 1:1.6:1.4, weighs spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylenes of 80g respectively Alkane] -4- ketone, α-chlorpromazine chloride of 75g and the N of 67g, N- diisopropylethylamine;According to spiral shell [2,3- dihydro -4H-1,3- benzo Piperazine -2,1'- hexamethylene] mass ratio of -4- ketone and dimethylformamide is 1:3.1, weigh 250g dimethylformamide;According to The mass ratio of [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone and methanol is 1:1.5, weighs 120g methanol.
Under nitrogen protection, by dimethylformamide, spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- Ketone, α-chlorpromazine chloride and n,N-diisopropylethylamine, which are added in four-hole boiling flask, is reacted, and the temperature of the reaction is 70 DEG C, instead The time answered is 6h.After reaction, it is down to room temperature, respectively three times with 200g washing, with the potassium bicarbonate solution of 250g10% It washes three times, three times with 200g washing, merges organic phase, be concentrated under reduced pressure into no liquid outflow.Then methanol is added, is cooled to -5 DEG C, stirring and crystallizing 2h is filtered, and drying obtains chlorine propionyl spiral shell benzoxazine hexamethylene 103.0g.Its molar yield is 90.9%, Purity is 99.1%.
Embodiment 6
According to spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride and tetrabutyl bromine The molar ratio for changing ammonium is 1:1.6:1.3, weighs the spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene]-of 80g respectively 4- ketone, α-chlorpromazine chloride of 75g and the tetrabutylammonium bromide of 154g;According to spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- Hexamethylene] mass ratio of -4- ketone and carbon tetrachloride is 1:3.1, weigh 250g carbon tetrachloride;According to [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] mass ratio of -4- ketone and ethyl alcohol is 1:1.5, weigh 120g ethyl alcohol.
Under nitrogen protection, by carbon tetrachloride, spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride and tetrabutylammonium bromide, which are added in four-hole boiling flask, is reacted, and the temperature of the reaction is 55 DEG C, reaction when Between be 8h.After reaction, it is down to room temperature, respectively three times with 200g washing, is washed three times with the potassium hydroxide solution of 250g9%, Three times with 200g washing, merge organic phase, be concentrated under reduced pressure into no liquid outflow.Then ethyl alcohol is added, is cooled to -5 DEG C, stirring analysis Brilliant 2h is filtered, and drying obtains chlorine propionyl spiral shell benzoxazine hexamethylene 104g.Its molar yield is 91.6%, and purity is 99.3%.
Embodiment 7
According to spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride and sodium carbonate Molar ratio is 1:1.6:1.1, weigh respectively 80g spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride of 75g and the sodium carbonate of 43g;According to spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone Mass ratio with tetrahydrofuran is 1:3.1, weighs 250g tetrahydrofuran;According to [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- Hexamethylene] mass ratio of -4- ketone and the tert-butyl alcohol is 1:1.5, weigh the 120g tert-butyl alcohol.
Under nitrogen protection, by tetrahydrofuran, spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride and sodium carbonate, which are added in four-hole boiling flask, to be reacted, and the temperature of the reaction is 60 DEG C, and the time of reaction is 7h. After reaction, it is down to room temperature, respectively three times with 200g washing, is washed three times with the sodium carbonate liquor of 250g9%, is washed with 200g Three times, merge organic phase, be concentrated under reduced pressure into no liquid outflow.Then the tert-butyl alcohol is added, is cooled to -5 DEG C, stirring and crystallizing 2h, mistake Filter, drying, obtains chlorine propionyl spiral shell benzoxazine hexamethylene 102g.Its molar yield is 90.0%, purity 99.2%.
Embodiment 8
According to spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride and ammonium carbonate Molar ratio is 1:1.6:1.2, weigh respectively 80g spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride of 75g and the ammonium carbonate of 42g;According to spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone Mass ratio with chloroform is 1:3.1, weighs 250g chloroform;According to [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] - The mass ratio of 4- ketone and n-butanol is 1:1.5, weighs 120g n-butanol.
Under nitrogen protection, by chloroform, spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorine Propionyl chloride and ammonium carbonate, which are added in four-hole boiling flask, to be reacted, and the temperature of the reaction is 55 DEG C, and the time of reaction is 8h.Reaction After, it is down to room temperature, respectively three times with 200g washing, is washed three times with the solution of potassium carbonate of 300g5%, with 200g washing three It is secondary, merge organic phase, is concentrated under reduced pressure into no liquid outflow.Then n-butanol is added, is cooled to -5 DEG C, stirring and crystallizing 2h, filters, Drying, obtains chlorine propionyl spiral shell benzoxazine hexamethylene 103g.Its molar yield is 90.8%, purity 99.1%.
Comparative example 1
According to rubbing for spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-bromopropionyl bromide and pyridine You weigh spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, 127g of 80g than being 1:1.6:1.4 respectively α-bromopropionyl bromide and 40g pyridine;According to spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone and chlorobenzene Mass ratio be 1:4.4, weigh 350g chlorobenzene;According to [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone with The mass ratio of ethyl alcohol is 1:1, weighs 80g ethyl alcohol.
Under nitrogen protection, by chlorobenzene, spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-bromine Propionyl bromide and pyridine, which are added in four-hole boiling flask, to be reacted, and the temperature of the reaction is 50 DEG C, and the time of reaction is 8h.Reaction knot Shu Hou is down to room temperature, respectively three times with 200g washing, is washed three times with the potassium hydroxide solution of 200g10%, with 200g washing three It is secondary, merge organic phase, is concentrated under reduced pressure into no liquid outflow.Then ethyl alcohol is added, is cooled to -5 DEG C, stirring and crystallizing 2h, filters, dries It is dry, obtain Spirobromin benzoxazine hexamethylene 109g.Its molar yield is 84.5%, purity 97.9%.
Comparative example 2
It is with α-chlorpromazine chloride molar ratio according to spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone 1:1.6, spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone and magnetic solid catalyst Mg6Al(OH)15CO3·4H2The molar ratio of O (magnetic solid base made from magnetic mg_al hydrotalcite) be 1:1.4, weigh respectively 80g spiral shell [2, 3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorpromazine chloride of 75g and the magnetic solid catalyst of 819g Mg6Al(OH)15CO3·4H2O;According to the matter of spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone and chlorobenzene Amount weighs 350g chlorobenzene than being 1:4.4;According to [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone and ethyl alcohol Mass ratio be 1:1, weigh 80g ethyl alcohol.
Under nitrogen protection, by chlorobenzene, spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-chlorine Propionyl chloride and magnetic solid base catalyst, which are added in four-hole boiling flask, to be reacted, and the temperature of the reaction is 50 DEG C, reaction when Between be 8h.After reaction, it is down to room temperature, respectively three times with 200g washing, is washed three times with the potassium hydroxide solution of 200g10%, Three times with 200g washing, merge organic phase, be concentrated under reduced pressure into no liquid outflow.Then ethyl alcohol is added, is cooled to -5 DEG C, stirring analysis Brilliant 2h is filtered, and drying obtains chlorine propionyl spiral shell benzoxazine hexamethylene 91g.Its molar yield is 85.5%, purity 96.5%.
Comparative example 3
It is with α-bromopropionyl bromide molar ratio according to spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone 1:1.6, spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone and magnetic solid catalyst Mg6Al(OH)15CO3·4H2The molar ratio of O (magnetic solid base made from magnetic mg_al hydrotalcite) be 1:1.4, weigh respectively 80g spiral shell [2, 3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-bromopropionyl bromide of 127g and 819g magnetic retention base catalysis Agent;It is 1:4.4 according to the mass ratio of spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone and chlorobenzene, weighs 350g chlorobenzene;It is 1:1 according to the mass ratio of [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone and ethyl alcohol, claims Take 80g ethyl alcohol.
Under nitrogen protection, by chlorobenzene, spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone, α-bromine Propionyl bromide and magnetic solid catalyst, which are added in four-hole boiling flask, to be reacted, and the temperature of the reaction is 50 DEG C, the time of reaction For 8h.After reaction, it is down to room temperature, respectively three times with 200g washing, is washed three times, is used with the potassium hydroxide solution of 200g10% 200g is washed three times, merges organic phase, is concentrated under reduced pressure into no liquid outflow.Then ethyl alcohol is added, is cooled to -5 DEG C, stirring and crystallizing 2h is filtered, and drying obtains Spirobromin benzoxazine hexamethylene 97g.Its molar yield is 75.0%, purity 97.1%.
Through the foregoing embodiment and comparative example, it can be seen that the present invention uses the lower α-chlorpromazine chloride of reactivity Cooperate other specific raw materials, not but not reduces reaction yield, instead reaction yield is greatly improved;Meanwhile by Lower in α-chlorpromazine chloride activity, so that the side reaction for participating in reaction is less, the impurity in products obtained from is less.The present invention By further controlling reaction temperature and material proportion, yield and the higher chlorine propionyl spiral shell benzoxazine hexamethylene of purity are obtained Alkane, and this yield and the higher chlorine propionyl spiral shell benzoxazine hexamethylene of purity can replace Spirobromin benzoxazine hexamethylene Prepare Meropenem.In addition, reaction condition is more in the synthesis technology of chlorine propionyl spiral shell benzoxazine hexamethylene provided by the invention Safety, reaction route is simple, convenient post-treatment, and raw material and catalyst are cheap and easy to get, and safety and environmental protection, preparation cost is lower, more suitable Close industrialized production.
The foregoing description of the disclosed embodiments enables those skilled in the art to implement or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, as defined herein General Principle can be realized in other embodiments without departing from the spirit or scope of the present invention.Therefore, of the invention It is not intended to be limited to the embodiments shown herein, and is to fit to and the principles and novel features disclosed herein phase one The widest scope of cause.

Claims (2)

1. a kind of preparation method of meropenem intermediate chlorine propionyl spiral shell benzoxazine hexamethylene, which is characterized in that including following Step:
By spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- hexamethylene] -4- ketone and α-chlorpromazine chloride under the action of acid binding agent Condensation reaction is carried out in aprotic solvent, obtains chlorine propionyl spiral shell benzoxazine hexamethylene;The condensation reaction is deposited in protection gas It carries out under the conditions;
The acid binding agent includes triethylamine, pyridine, N, N- diisopropylethylamine, 4-dimethylaminopyridine, triethanolamine, the tetrabutyl One or more of ammonium bromide, potassium carbonate, ammonium carbonate and sodium carbonate;
Mole of spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- the hexamethylene] -4- ketone, α-chlorpromazine chloride and acid binding agent Than for 1:1.0~2.5:0.5~3.0;
The mass ratio of spiral shell [2,3- dihydro -4H-1,3- Benzoxazine -2,1'- the hexamethylene] -4- ketone and aprotic solvent is 1: 1.0~5.0;
The aprotic solvent is toluene, dimethylbenzene, benzene, chlorobenzene, nitrobenzene, acetone, dimethylformamide, tetrahydrofuran, two One or more of chloromethanes, chloroform and carbon tetrachloride;
The temperature of the condensation reaction is 50~90 DEG C, and the time of the condensation reaction is 0.5~20h.
2. preparation method according to claim 1, which is characterized in that further include in proton solvent after the condensation reaction Middle cooling crystallization.
CN201610812510.8A 2016-09-08 2016-09-08 A kind of preparation method of meropenem intermediate chlorine propionyl spiral shell benzoxazine hexamethylene Active CN106432122B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610812510.8A CN106432122B (en) 2016-09-08 2016-09-08 A kind of preparation method of meropenem intermediate chlorine propionyl spiral shell benzoxazine hexamethylene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610812510.8A CN106432122B (en) 2016-09-08 2016-09-08 A kind of preparation method of meropenem intermediate chlorine propionyl spiral shell benzoxazine hexamethylene

Publications (2)

Publication Number Publication Date
CN106432122A CN106432122A (en) 2017-02-22
CN106432122B true CN106432122B (en) 2018-12-07

Family

ID=58167486

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610812510.8A Active CN106432122B (en) 2016-09-08 2016-09-08 A kind of preparation method of meropenem intermediate chlorine propionyl spiral shell benzoxazine hexamethylene

Country Status (1)

Country Link
CN (1) CN106432122B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108774188A (en) * 2018-07-23 2018-11-09 湖北宇阳药业有限公司 A kind of preparation method of meropenem intermediate
CN110025619B (en) * 2019-04-29 2022-03-22 江苏汉阔生物有限公司 Application of meropenem intermediate in preparation of antioxidant drugs

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011150A (en) * 1992-11-13 2000-01-04 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
CN102321044A (en) * 2011-07-20 2012-01-18 江西华邦药业有限公司 Preparation method of 3-(2-bromo propionyl)-spiro[2H-1,3-benzoxazine-2,1'-cyclohexane]-4(3H)-one
CN106478538A (en) * 2015-08-28 2017-03-08 曹子领 Chlorine propionyl spiral shell benzimidazole dihydrochloride hexamethylene and its synthesis and application

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011150A (en) * 1992-11-13 2000-01-04 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
CN102321044A (en) * 2011-07-20 2012-01-18 江西华邦药业有限公司 Preparation method of 3-(2-bromo propionyl)-spiro[2H-1,3-benzoxazine-2,1'-cyclohexane]-4(3H)-one
CN106478538A (en) * 2015-08-28 2017-03-08 曹子领 Chlorine propionyl spiral shell benzimidazole dihydrochloride hexamethylene and its synthesis and application

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
2-Substituted 2,3-Dihydro-4H-1,3-benzoxazin-4-ones: A Novel Auxiliary for Stereoselective Synthesis of 1-β-Methylcarbapenems;Kazuhiko Kondo 等;《J. Org. Chem.》;19951231;第60卷(第5期);1096-1097 *
比阿陪南双环母核的合成;宗杰 等;《合成化学》;20081231;第16卷(第5期);596-599 *

Also Published As

Publication number Publication date
CN106432122A (en) 2017-02-22

Similar Documents

Publication Publication Date Title
CN106432122B (en) A kind of preparation method of meropenem intermediate chlorine propionyl spiral shell benzoxazine hexamethylene
CN104844502B (en) A kind of preparation method of Mo Fanselin
CN104230852B (en) The fertile synthetic method for Xi Ting
CN107540601A (en) The convenient preparation method of 5R benzyloxies amino piperidine 2S formic acid esters and its oxalates
CN101955457A (en) General preparation method of optical-activity 3-aminopyrrolidine, 3-alkyl amino piperidine and derivatives thereof
CN106316898B (en) The synthetic method of Florfenicol
CN106397473B (en) A kind of preparation method of meropenem intermediate 4-BMA
CN104387299B (en) The preparation method of 4-amino-N-[(2R, 3S)-3-amino-2-hydroxyl-4-benzene butyl]-N-isobutyl-benzene sulfonamide
CN103570601B (en) A kind of preparation method of optical active medicine intermediate
CN101043888B (en) Processes for the preparation of isothiazole derivatives
CN105481856B (en) A kind of preparation method of 9-hydroxy-risperidone
CN104918912B (en) Processes for the synthesis of 2-amino-4,6-dimethoxybenzamide and other benzamide compounds
CN103613562B (en) A kind of preparation method of pramipexole
CN113831333A (en) Synthetic method of sulfuryl pyraflufen
CN106279175A (en) A kind of preparation method of Ertapenem Sodium
CN103755696B (en) A kind of synthetic method of Nifuratel
CN108586493A (en) A kind of preparation method of crystal type CEFUROXIME AXETIL
CN103172574B (en) Novel synthesis process of 2-substituted-4,6-dialkoxy pyrimidine
CN105732660B (en) The preparation method of lavo-ofloxacin intermediate
CN105017379B (en) A kind of green synthesis method of high-purity dutasteride
CN106916074A (en) The preparation of tomoxetine hydrochloride
CN102887856A (en) Method for synthesizing Blonanserin
CN106631812B (en) A kind of Boscalid intermediate 4 '-chloro- 2- nitro -1,1 '-biphenyl preparation method
CN103044345B (en) A kind of synthetic method of 1-(2-hydroxyethyl)-5-sulfydryl-1H-tetrazole
CN115073350B (en) Preparation method of eremophilone

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant